RE:RE:40,000 required, very interesting but where? Here's your nr more news expected next week , keep the sales coming
Dear Friend;
Attached is the news release for today. Here is some background:
1. The Peter Munck Cardiac Centre (PMCC) in Toronto sees the most patients with heart disease in Canada. Their referral area goes all the way to James Bay!
2. Since it is located next to The Hopsital for Sick Children (HSK), it has a very active congenital heart disease group, which of course focuses on the right heart.
3. PMCC has been following the Company’s progress for many years and we are delighted that they have now adopted our technology and installed our VMS+3.0 product.
4. While the initial focus will be for patients with right-heart dysfunction in PH and CHD, we would expect others in the echocardiography unit to begin to use it on other patients as well.
5. Dr. John Granton is not a cardiologist but rather the head of respirology (The study and treatment of diseases of the lungs and respiratory tract). He is world renown for his work in Pulmonary Hypertension (also a right heart problem).
7. As you can imagine with all the COVID patients in Toronto with respiratory problems, John’s plate is full right now and still he has made the effort to bring in the VMS+3.0. Given the many reports or RV dilation and its correlation with death in COVID patents, it is forward thinking to have a VMS+3.0 available to assess and monitor COVID patients. Other hopsitals are also thinking this way.
8. I remember visiting Dr. Simon Gibbs (a leading cardiologist who specializes in PH in the UK) and having him say to me that he wished respirologists would send him the patents earlier as often the patient's hearts are so damaged there is little he can do. I am pleased to report that this is not the case at PMCC where they work closely to make sure people at risk for PH (and remember it affects individuals from 2 to 90 years old) are evaluated for heart complications in a timely fashion.
9. John works with Dr. Erwin Oechslin, cardiologist who runs the adult CHD clinic at PMCC and consults to HSK. Erwin has been a long-time supporter of Ventripoint and is especially pleased to have a VMS+3.0.
10. This installation continues our marketing strategy to have Knowledge Opinion Leaders (KOLs) adopting our products and agreeing to speak about their experiences at future major medical conferences. As an added bonus, it is right here in Toronto.
11. It has been a busy month since we returned to trading with 3 installations in 3 globally-rated top hospitals (USA, Europe and Canada) as well as trading more than 100,000,000 shares.
12. As I have often said, not much I can do about the share price but keep building value in the Company, especially with such large volumes. Still it is great liquidity to allow people to get in and get out. Excellent base of shareholders here to build on.
Thanks for your continued interest and support as we continue to reduce the number of children being traumatized in MRI machines and improve cardiac diagnostics for everyone.